Santo Therapeutics Revenue
Biotechnology Research • • 1-10 Employees
Santo Therapeutics revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at Santo Therapeutics
Lu Zhou
Founder
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
About Santo Therapeutics
Santo Therapeutics is established by experienced genetic scientists and biotechnological experts from University of Cambridge, University College London, etc. Technical team are excellent in the development and manufacture of novel viral vector and manufacture. With our next generation viral vector platforms, Santo Therapeutics is committed to develop in house Pipeline programs to treat rare diseases with highly unmet medical need worldwide. The current projects involves in neurodegenerative and neuro-oncological diseases. Also, we are interested in partnerships with biopharmaceutical players in other disease areas.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Santo Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Santo Therapeutics has never raised funding before.
France
United Arab Emirates
South Africa
Bulgaria
Frequently asked questions
4.8
40,000 users
